These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33892271)

  • 1. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
    Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
    Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
    Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo.
    Kaniakova M; Korabecny J; Holubova K; Kleteckova L; Chvojkova M; Hakenova K; Prchal L; Novak M; Dolezal R; Hepnarova V; Svobodova B; Kucera T; Lichnerova K; Krausova B; Horak M; Vales K; Soukup O
    Biochem Pharmacol; 2021 Apr; 186():114460. PubMed ID: 33571502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and
    Konecny J; Misiachna A; Hrabinova M; Pulkrabkova L; Benkova M; Prchal L; Kucera T; Kobrlova T; Finger V; Kolcheva M; Kortus S; Jun D; Valko M; Horak M; Soukup O; Korabecny J
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.
    Chvojkova M; Kolar D; Kovacova K; Cejkova L; Misiachna A; Hakenova K; Gorecki L; Horak M; Korabecny J; Soukup O; Vales K
    Biomed Pharmacother; 2024 Jul; 176():116821. PubMed ID: 38823278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel conjugates of tacrine with 1,2,4,-thiadiazole as highly effective cholinesterase inhibitors, blockers of NMDA receptors, and antioxidants.
    Makhaeva GF; Grigoriev VV; Proshin AN; Kovaleva NV; Rudakova EV; Boltneva NP; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2017 Nov; 477(1):405-409. PubMed ID: 29297118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
    Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
    Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors.
    Li W; Pi R; Chan HH; Fu H; Lee NT; Tsang HW; Pu Y; Chang DC; Li C; Luo J; Xiong K; Li Z; Xue H; Carlier PR; Pang Y; Tsim KW; Li M; Han Y
    J Biol Chem; 2005 May; 280(18):18179-88. PubMed ID: 15710623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J
    Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
    Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
    Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.
    Ansari F; Ghasemi JB; Niazi A
    Med Chem; 2020; 16(2):155-168. PubMed ID: 31092184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers.
    Hamulakova S; Imrich J; Janovec L; Kristian P; Danihel I; Holas O; Pohanka M; Böhm S; Kozurkova M; Kuca K
    Int J Biol Macromol; 2014 Sep; 70():435-9. PubMed ID: 25036600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.